These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 23603496
1. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus. Laosutthipong C, Kanthong N, Flegel TW. Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496 [Abstract] [Full Text] [Related]
2. Insect anionic septapeptides suppress DENV replication by activating antiviral cytokines and miRNAs in primary human monocytes. Limthongkul J, Mapratiep N, Apichirapokey S, Suksatu A, Midoeng P, Ubol S. Antiviral Res; 2019 Aug; 168():1-8. PubMed ID: 31075349 [Abstract] [Full Text] [Related]
3. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Talarico LB, Pujol CA, Zibetti RG, Faría PC, Noseda MD, Duarte ME, Damonte EB. Antiviral Res; 2005 Jun; 66(2-3):103-10. PubMed ID: 15911027 [Abstract] [Full Text] [Related]
4. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT. Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143 [Abstract] [Full Text] [Related]
5. Narasin, a novel antiviral compound that blocks dengue virus protein expression. Low JS, Wu KX, Chen KC, Ng MM, Chu JJ. Antivir Ther; 2011 Nov; 16(8):1203-18. PubMed ID: 22155902 [Abstract] [Full Text] [Related]
6. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication. Lee JC, Tseng CK, Wu YH, Kaushik-Basu N, Lin CK, Chen WC, Wu HN. Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455 [Abstract] [Full Text] [Related]
7. Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells. Acosta EG, Piccini LE, Talarico LB, Castilla V, Damonte EB. Virus Res; 2014 May 12; 184():39-43. PubMed ID: 24583230 [Abstract] [Full Text] [Related]
8. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection. Alen MM, Dallmeier K, Balzarini J, Neyts J, Schols D. Antiviral Res; 2012 Dec 12; 96(3):280-7. PubMed ID: 23124109 [Abstract] [Full Text] [Related]
9. The antimicrobial peptide HS-1 inhibits dengue virus infection. Monteiro JMC, Oliveira MD, Dias RS, Nacif-Marçal L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO. Virology; 2018 Jan 15; 514():79-87. PubMed ID: 29153860 [Abstract] [Full Text] [Related]
10. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus. Soto-Acosta R, Bautista-Carbajal P, Syed GH, Siddiqui A, Del Angel RM. Antiviral Res; 2014 Sep 15; 109():132-40. PubMed ID: 25017471 [Abstract] [Full Text] [Related]
11. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide. Chew MF, Tham HW, Rajik M, Sharifah SH. J Appl Microbiol; 2015 Oct 15; 119(4):1170-80. PubMed ID: 26248692 [Abstract] [Full Text] [Related]
12. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J, Schols D. Virology; 2009 Apr 25; 387(1):67-75. PubMed ID: 19264337 [Abstract] [Full Text] [Related]
13. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells. Beesetti H, Tyagi P, Medapi B, Krishna VS, Sriram D, Khanna N, Swaminathan S. Antivir Ther; 2018 Apr 25; 23(5):385-394. PubMed ID: 29583121 [Abstract] [Full Text] [Related]
14. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. Tay MY, Fraser JE, Chan WK, Moreland NJ, Rathore AP, Wang C, Vasudevan SG, Jans DA. Antiviral Res; 2013 Sep 25; 99(3):301-6. PubMed ID: 23769930 [Abstract] [Full Text] [Related]
15. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM). Pires de Mello CP, Drusano GL, Rodriquez JL, Kaushik A, Brown AN. Viruses; 2018 Jun 09; 10(6):. PubMed ID: 29890736 [Abstract] [Full Text] [Related]
16. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. Abdul Ahmad SA, Palanisamy UD, Tejo BA, Chew MF, Tham HW, Syed Hassan S. Virol J; 2017 Nov 21; 14(1):229. PubMed ID: 29162124 [Abstract] [Full Text] [Related]
17. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S. Virol J; 2011 Dec 28; 8():560. PubMed ID: 22201648 [Abstract] [Full Text] [Related]
18. Ten years of dengue drug discovery: progress and prospects. Lim SP, Wang QY, Noble CG, Chen YL, Dong H, Zou B, Yokokawa F, Nilar S, Smith P, Beer D, Lescar J, Shi PY. Antiviral Res; 2013 Nov 28; 100(2):500-19. PubMed ID: 24076358 [Abstract] [Full Text] [Related]
19. Peptide inhibitors against dengue virus infection. Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT. Chem Biol Drug Des; 2014 Aug 28; 84(2):148-57. PubMed ID: 24612829 [Abstract] [Full Text] [Related]
20. Infection of epithelial cells with dengue virus promotes the expression of proteins favoring the replication of certain viral strains. Martínez-Betancur V, Marín-Villa M, Martínez-Gutierrez M. J Med Virol; 2014 Aug 28; 86(8):1448-58. PubMed ID: 24374781 [Abstract] [Full Text] [Related] Page: [Next] [New Search]